Lysophosphatidylcholine produced by the phospholipase A2 isolated from Lachesis muta snake venom modulates natural killer activity as a protein kinase C effector

Toxicon

Volumn 50, Issue 3, 2007, Pages 400-410

  Fuly, André L ^a   Machado, Alexandre L ^b   Castro, Paulo ^b   Abrahão, Agessandro ^b   Redner, Paulo ^b   Lopes, Ulisses G ^b   Guimarães, Jorge A ^c   Koatz, Vera Lucia G ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Lachesis muta; Lymphocytes; Lysophosphatidylcholine; Phospholipase A2; Protein kinase C; Snake venom

Indexed keywords

4 BROMOPHENACYL BROMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PROTEIN KINASE C; PROTEIN KINASE C ZETA; SNAKE VENOM; STAUROSPORINE;

ARTICLE; AUTOPHOSPHORYLATION; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME PHOSPHORYLATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LACHESIS MUTA; LYMPHOCYTE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SNAKE;

ANIMALS; CELL LINE, TUMOR; CROTALID VENOMS; HUMANS; KILLER CELLS, NATURAL; LYSOPHOSPHATIDYLCHOLINES; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN KINASE C; STAUROSPORINE; VIPERIDAE;

LACHESIS MUTA;

EID: 34447618610     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2007.04.008     Document Type: Article

References (42)

1. (2) regulation of arachidonic acid mobilization. FEBS Lett. 531 (2002) 2-6
2. Caccin P., Rigoni M., Biscegli A., Rosseto O., and Montecucco C. Reversible skeletal neuromuscular paralysis induced by different lysophospholipids. FEBS Lett. (2006) 6317-6321
3. Castro P., Legora-Machado A., Cardilo-Reis L., Valença S.S., Porto L.C., Walker C., Zuany-Amorim C., and Koatz V.L.G. Inhibition of interleukin-1 beta reduces mouse lung inflammation induced by exposure to cigarette smoke. Eur. J. Pharmacol. 498 (2004) 279-286
4. Chow S.C., Nordstedt C., Fredholm B.B., and Jondal M. Phosphoinositide breakdown and evidence for protein kinase C involvement during human NK killing. Cell. Immunol. 114 (1988) 96-103
5. 2 activation and arachidonic acid metabolismo in the cytotoxic functions of rat NK cells. Cell. Immunol. 148 (1993) 247-258
6. Compton M.M., Gibbs P.S., and Johnson L.R. Glucocorticoid activation of deoxyribonucleic acid degradation in bursal lymphocytes. Poult. Sci. 69 (1990) 1292-1298
7. Croset M., Brossard N., Polette A., and Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem. J. 345 (2000) 61-67
8. 2. Cell. Immunol. 110 (1987) 253-264
9. de Moraes V.L., Olej B., de la Rocque L., and Rumjanek V.M. Lack of sensitivity to ouabain in natural killer activity. FASEB J. 3 (1989) 2425-2429
10. Dennis E.A., Rhee S.G., Billah M.M., and Hannun Y.A. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J. 5 (1991) 2068-2077
11. Diaz C., Leon G., Rucavado A., Rojas N., Schroit A.J., and Gutiérrez J.M. Modulation of the susceptibility of human erythrocytes to snake venom myotoxic phospholipases A(2): role of charged phospholipids as potential membrane binding sites. Arch. Biochem. Biophys. 391 (2001) 56-64
12. Even-Faitelson L., and Ravid S. PAK1 and aPKCζ regulate myosin II-B phosphorylation: a novel signaling pathway regulating filament assembly. Mol. Biol. Cell. 17 (2006) 2869-2881
13. Fabbri M., Smart C., and Pardi R. T lymphocytes. Int. J. Biochem. Cell Biol. 35 (2003) 1004-1008
14. 2 isolated from Lachesis muta (Bushmaster) snake venom. Thromb. Haemost. 78 (1997) 1372-1380
15. 2 isolated from Lachesis muta (Bushmaster) snake venom. Toxicon 38 (2000) 961-972
16. 2 isolated from Lachesis muta snake venom. Comparison with lysophosphatidylcholine. Int. J. Biochem. Cell Biol. 35 (2003) 1470-1481
17. 2 enzymes: regulation and inhibition. Trends Pharmacol. Sci. 14 (1993) 92-98
18. Graves S.S., Bramhall J., and Bonavida B. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity. J. Immunol. 137 (1986) 1977-1984
19. 2 activation in cytotoxicity by human natural killer cells. Proc. Natl Acad. Sci. (USA) 78 (1981) 3839-3843
20. Kabarowski J.H., Zhu K., Le L.Q., Witte O.N., and Xu Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293 (2001) 702-705
21. Kabarowski J.H., Xu Y., and Witte O.N. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 64 (2002) 161-167
22. Kazuhiko O., Raynor R.L., Charp P.A., and Kuo J.F. Regulation of protein kinase C by lysophospholipids. J. Biol. Chem. 263 (1998) 6865-6871
23. Keenan C., and Kelleher D. Protein kinase C and the cytoskeleton. Cell. Signal. 10 (1998) 225-232
24. Keenan C., Volkov Y., Kelleher D., and Long A. Subcellular localization and translocation of protein kinase C isoforms zeta and epsilon in human peripheral blood lymphocytes. Int. Immunol. 9 (1997) 1431-1439
25. 2 enzymes: Structure, function and mechanism (1997), Wiley, Chichester 1-28
26. 2 enzymes. Toxicon 42 (2003) 827-840
27. Littler D.D., Walker J.R., She Y.M., Finerty Jr. P.J., Newman E.M., and Dhe-Paganon S. Structure of human protein kinase C eta (PKCη) C2 domain and identification of phosphorylation sites. Biochem. Biophys. Res. Commun. 349 (2006) 1182-1189
28. Lowry O.H., Rosebrough N.S., Farr A.L., and Randall R.J. Protein measurement with the Folin reagent. J. Biol. Chem. 193 (1951) 265-275
29. Masamune A., Sakai Y., Yoshida M., Satoh A., Satoh K., and Shimosegawa T. Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells. Dig. Dis. Sci. 46 (2001) 1871-1881
30. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274 (1999) 3101-3115
31. Nishizuka Y. Discovery and prospect of protein kinase C research: epilogue. J. Biochem. 133 (2003) 155-158
32. Pestronk A., Parhad I.M., Drachman D.B., and Price D.L. Membrane myopathy: morphological similarities to Duchenne muscular dystrophy. Muscle Nerve 5 (1982) 209-214
33. Prokazova N.V., Zvezdina N.D., and Korotaeva A.A. Effect of lysophosphatidylcholine on transmembrane signal transduction. Biochemistry (Mosc) 63 (1998) 31-37
34. 2 neurotoxins and lysophospholipid-fatty acid mixtures. Science 310 (2005) 1678-1680
35. Schilling T., Lehmann F., Ruckert B., and Eder C. Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J. Physiol. 557 (2004) 105-120
36. Six D.A., and Dennis E.A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta 1488 (2000) 1-19
37. Steele T.A., and Brahmi Z. Phosphatidylinositol metabolism accompanies early activation events in tumor target cell-stimulated human natural killer cells. Cell. Immunol. 112 (1988) 402-413
38. Sugiyama S., Kugiyama K., Ogata N., Doi H., Ota Y., Ohgushi M., Matsumura T., Oka H., and Yasue H. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Ather. Thromb. Vasc. Biol. 18 (1998) 568-576
39. Whalen M.M., Doshi R.N., Bader B.W., and Bankhurst A.D. Lysophosphatidylcholine and arachidonic acid are required in the cytotoxic response of human natural killer cells to tumor target cells. Cell. Physiol. Biochem. 9 (1999) 297-309
40. Xu Y. Sphingosylphosphorylchoine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim. Biophys. Acta 1582 (2002) 81-88
41. Yasuda I., Kishimoto A., Tanaka S., Tominaga M., Sakurai A., and Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166 (1990) 1220-1227
42. Zhu K., Baudhuin L.M., Hong G., Williams F.S., Cristina K.L., Kabarowski J.H., Witte O.N., and Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276 (2001) 41325-41335